Want to learn more about pulmonary arterial hypertension (PAH)?
PAH is a rare and incurable condition that can have a negative impact on patients.1 PAH shares symptoms with other more common conditions and is frequently overlooked or misdiagnosed. Early referral, diagnosis and access to the right treatment is vital for those affected and can significantly improve survival.2–5
Act on PAH has been developed with pulmonary hypertension (PH) specialists to provide information for healthcare professionals about PAH. You can browse resources tailor-made for your speciality, such as how to interpret echocardiograms, learn more about referral, symptoms and diagnosis, and keep up-to-date with guidelines and educational events.
It is time to act and improve patient outcomes with earlier diagnosis.
Find out more
Act on PAH is part of the Janssen Medical Cloud, where you can find resources for healthcare professionals about a range of therapy areas.
1. Galiè N, et al. Eur Heart J. 2016;37:67–119; 2. Humbert M, et al. Circulation. 2010;122:156–163; 3. Humbert M, et al. Eur Respir J. 2010;36:549–555; 4.Condliffe R, et al. Am J Respir Crit Care Med. 2009;179:151–157; 5. Dimopoulos K, et al. Circulation. 2010;121:20–25.
Developed and funded by Janssen-Cilag Ltd to provide information for healthcare professionals.
EM-41222 | September 2020